Reductive amination in the synthesis of pharmaceuticals

OI Afanasyev, E Kuchuk, DL Usanov… - Chemical reviews, 2019 - ACS Publications
Reductive amination plays a paramount role in pharmaceutical and medicinal chemistry
owing to its synthetic merits and the ubiquitous presence of amines among biologically …

Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001–2011)

J Wang, M Sánchez-Roselló, JL Aceña… - Chemical …, 2014 - ACS Publications
1.1. Brief Historical Overview As expected from the fluorine position on the periodic table of
elements, it possesses some extreme properties, in particular, ultimate electronegativity and …

Polymorphism of human cytochrome P450 enzymes and its clinical impact

SF Zhou, JP Liu, B Chowbay - Drug metabolism reviews, 2009 - Taylor & Francis
Pharmacogenetics is the study of how interindividual variations in the DNA sequence of
specific genes affect drug response. This article highlights current pharmacogenetic …

Pharmacokinetics of selective serotonin reuptake inhibitors

C Hiemke, S Härtter - Pharmacology & therapeutics, 2000 - Elsevier
The five selective serotonin reuptake inhibitors (SSRIs), fluoxetine, fluvoxamine, paroxetine,
sertraline, and citalopram, have similar antidepressant efficacy and a similar side effect …

para-C–H Borylation of Benzene Derivatives by a Bulky Iridium Catalyst

Y Saito, Y Segawa, K Itami - Journal of the American Chemical …, 2015 - ACS Publications
A highly para-selective aromatic C–H borylation has been accomplished. By a new iridium
catalyst bearing a bulky diphosphine ligand, Xyl-MeO-BIPHEP, the C–H borylation of …

Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine

MJ Owens, DL Knight, CB Nemeroff - Biological psychiatry, 2001 - Elsevier
Background: Single isomers of the selective serotonin reuptake inhibitors citalopram
(escitalopram, S-citalopram) and fluoxetine (R-fluoxetine) are currently under development …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding

C Sánchez, J Hyttel - Cellular and molecular neurobiology, 1999 - Springer
The present survey compares the effects of antidepressants and their principal metabolites
on reuptake of biogenic amines and on receptor binding. The following antidepressants …

Clinically relevant pharmacology of selective serotonin reuptake inhibitors: an overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism

SH Preskorn - Clinical pharmacokinetics, 1997 - Springer
This paper presents an overview of the clinically relevant pharmacology of selective
serotonin reuptake inhibitors (SSRIs) with an emphasis on their pharmacokinetics and …

CYP2D6 and CYP2C19 genotype‐based dose recommendations for antidepressants: a first step towards subpopulation‐specific dosages

J Kirchheiner, K Brøsen, ML Dahl… - Acta Psychiatrica …, 2001 - Wiley Online Library
Objective: This review aimed to provide distinct dose recommendations for antidepressants
based on the genotypes of cytochrome P450 enzymes CYP2D6 and CYP2C19. This …